vs

Side-by-side financial comparison of Spectral AI, Inc. (MDAI) and TON Strategy Co (TONX). Click either name above to swap in a different company.

TON Strategy Co is the larger business by last-quarter revenue ($5.7M vs $4.1M, roughly 1.4× Spectral AI, Inc.). Spectral AI, Inc. runs the higher net margin — 25.7% vs -3968.6%, a 3994.3% gap on every dollar of revenue. On growth, TON Strategy Co posted the faster year-over-year revenue change (694.2% vs -46.3%). Over the past eight quarters, TON Strategy Co's revenue compounded faster (46.1% CAGR vs -19.6%).

Spectral AI, Inc. is a medical technology firm specializing in AI-powered diagnostic imaging solutions primarily for burn and wound care. It develops non-invasive imaging tools that enable healthcare providers to deliver faster, more accurate treatment assessments, serving clinical and healthcare partner networks across North America and European markets.

MDAI vs TONX — Head-to-Head

Bigger by revenue
TONX
TONX
1.4× larger
TONX
$5.7M
$4.1M
MDAI
Growing faster (revenue YoY)
TONX
TONX
+740.5% gap
TONX
694.2%
-46.3%
MDAI
Higher net margin
MDAI
MDAI
3994.3% more per $
MDAI
25.7%
-3968.6%
TONX
Faster 2-yr revenue CAGR
TONX
TONX
Annualised
TONX
46.1%
-19.6%
MDAI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MDAI
MDAI
TONX
TONX
Revenue
$4.1M
$5.7M
Net Profit
$1.1M
$-227.9M
Gross Margin
45.2%
64.3%
Operating Margin
-54.9%
-159.2%
Net Margin
25.7%
-3968.6%
Revenue YoY
-46.3%
694.2%
Net Profit YoY
113.9%
-7047.9%
EPS (diluted)
$0.04
$-3.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDAI
MDAI
TONX
TONX
Q4 25
$4.1M
$5.7M
Q3 25
$3.8M
$3.6M
Q2 25
$5.1M
$2.1M
Q1 25
$6.7M
$1.3M
Q4 24
$7.6M
$723.0K
Q3 24
$8.2M
Q2 24
$7.5M
Q1 24
$6.3M
Net Profit
MDAI
MDAI
TONX
TONX
Q4 25
$1.1M
$-227.9M
Q3 25
$-3.6M
$84.3M
Q2 25
$-8.0M
$-2.4M
Q1 25
$2.9M
$-2.6M
Q4 24
$-7.6M
$-3.2M
Q3 24
$-1.5M
Q2 24
$-2.9M
Q1 24
$-3.2M
Gross Margin
MDAI
MDAI
TONX
TONX
Q4 25
45.2%
64.3%
Q3 25
42.7%
75.4%
Q2 25
45.2%
71.2%
Q1 25
47.2%
73.4%
Q4 24
44.0%
81.5%
Q3 24
44.9%
Q2 24
44.3%
Q1 24
46.6%
Operating Margin
MDAI
MDAI
TONX
TONX
Q4 25
-54.9%
-159.2%
Q3 25
-88.1%
-601.5%
Q2 25
-41.9%
-138.2%
Q1 25
-13.4%
-203.8%
Q4 24
-14.6%
-513.1%
Q3 24
-10.8%
Q2 24
-32.7%
Q1 24
-33.9%
Net Margin
MDAI
MDAI
TONX
TONX
Q4 25
25.7%
-3968.6%
Q3 25
-93.7%
2336.8%
Q2 25
-157.3%
-111.9%
Q1 25
43.2%
-196.5%
Q4 24
-99.8%
-440.9%
Q3 24
-18.4%
Q2 24
-38.3%
Q1 24
-50.7%
EPS (diluted)
MDAI
MDAI
TONX
TONX
Q4 25
$0.04
$-3.89
Q3 25
$-0.13
$2.23
Q2 25
$-0.31
$-1.79
Q1 25
$0.11
$-2.51
Q4 24
$-0.42
$10.41
Q3 24
$-0.08
Q2 24
$-0.16
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDAI
MDAI
TONX
TONX
Cash + ST InvestmentsLiquidity on hand
$15.4M
$39.5M
Total DebtLower is stronger
$9.3M
Stockholders' EquityBook value
$-5.7M
$406.5M
Total Assets
$21.4M
$411.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDAI
MDAI
TONX
TONX
Q4 25
$15.4M
$39.5M
Q3 25
$10.5M
$53.9M
Q2 25
$10.5M
$10.4M
Q1 25
$14.1M
$12.2M
Q4 24
$5.2M
$12.5M
Q3 24
$3.7M
Q2 24
$6.9M
Q1 24
$10.2M
Total Debt
MDAI
MDAI
TONX
TONX
Q4 25
$9.3M
Q3 25
Q2 25
Q1 25
$7.8M
Q4 24
$2.8M
Q3 24
$1.0M
Q2 24
Q1 24
Stockholders' Equity
MDAI
MDAI
TONX
TONX
Q4 25
$-5.7M
$406.5M
Q3 25
$-8.2M
$639.1M
Q2 25
$-9.2M
$19.4M
Q1 25
$-1.6M
$14.6M
Q4 24
$-7.3M
$16.2M
Q3 24
$-4.8M
Q2 24
$-4.7M
Q1 24
$-2.5M
Total Assets
MDAI
MDAI
TONX
TONX
Q4 25
$21.4M
$411.2M
Q3 25
$15.3M
$661.9M
Q2 25
$16.0M
$23.7M
Q1 25
$20.7M
$18.4M
Q4 24
$12.1M
$20.6M
Q3 24
$11.6M
Q2 24
$13.9M
Q1 24
$15.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDAI
MDAI
TONX
TONX
Operating Cash FlowLast quarter
$-2.6M
$-8.0M
Free Cash FlowOCF − Capex
$-8.0M
FCF MarginFCF / Revenue
-139.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-2.43×
TTM Free Cash FlowTrailing 4 quarters
$-20.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDAI
MDAI
TONX
TONX
Q4 25
$-2.6M
$-8.0M
Q3 25
$-2.5M
$-9.4M
Q2 25
$-3.4M
$-2.3M
Q1 25
$-1.5M
$-1.1M
Q4 24
$469.0K
$-1.9M
Q3 24
$-1.6M
Q2 24
$-5.4M
Q1 24
$-2.7M
Free Cash Flow
MDAI
MDAI
TONX
TONX
Q4 25
$-8.0M
Q3 25
$-9.4M
Q2 25
$-2.3M
Q1 25
$-1.1M
Q4 24
$-2.0M
Q3 24
Q2 24
Q1 24
FCF Margin
MDAI
MDAI
TONX
TONX
Q4 25
-139.3%
Q3 25
-261.4%
Q2 25
-107.8%
Q1 25
-87.0%
Q4 24
-279.9%
Q3 24
Q2 24
Q1 24
Capex Intensity
MDAI
MDAI
TONX
TONX
Q4 25
0.1%
Q3 25
0.4%
Q2 25
0.1%
Q1 25
5.1%
Q4 24
22.1%
Q3 24
Q2 24
Q1 24
Cash Conversion
MDAI
MDAI
TONX
TONX
Q4 25
-2.43×
Q3 25
-0.11×
Q2 25
Q1 25
-0.52×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDAI
MDAI

Segment breakdown not available.

TONX
TONX

Market Live$4.8M83%
Other$960.0K17%

Related Comparisons